| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |